Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 254
Filter
Add more filters

Country/Region as subject
Publication year range
2.
Br J Cancer ; 102(5): 844-51, 2010 Mar 02.
Article in English | MEDLINE | ID: mdl-20145621

ABSTRACT

BACKGROUND: Gastric cancer cells frequently metastasise, partly because of their highly invasive nature. Transforming growth factor-beta (TGF-beta) receptor signalling is closely associated with the invasion of cancer cells. The aim of this study was to clarify the effect of a TGF-beta receptor (TbetaR) phosphorylation inhibitor on the invasiveness of gastric cancer cells. METHODS: Four gastric cancer cell lines, including two scirrhous-type cell lines and two non-scirrhous-type cell lines, were used. A TbetaR type I (TbetaR-I) kinase inhibitor, Ki26894, inhibits the phosphorylation of Smad2 at an ATP-binding site of TbetaR-I. We investigated the expression levels of TbetaR and phospho-Smad2, and the effects of TGF-beta in the presence or absence of Ki26894 on Smad2 phosphorylation, invasion, migration, epithelial-to-mesenchymal transition (EMT), Ras homologue gene family member A (RhoA), ZO-2, myosin, and E-cadherin expression of gastric cancer cells. RESULTS: TbetaR-I, TbetaR-II, and phospho-Smad2 expressions were found in scirrhous gastric cancer cells, but not in non-scirrhous gastric cancer cells. Ki26894 decreased Smad2 phosphorylation induced by TGF-beta1 in scirrhous gastric cancer cells. Transforming growth factor-beta1 upregulated the invasion, migration, and EMT ability of scirrhous gastric cancer cells. Transforming growth factor-beta1 significantly upregulated the activity of RhoA and myosin phosphorylation, whereas TGF-beta1 decreased ZO-2 and E-cadherin expression in scirrhous gastric cancer cells. Interestingly, Ki26894 inhibited these characteristics in scirrhous gastric cancer cells. In contrast, non-scirrhous gastric cancer cells were not affected by TGF-beta1 or Ki26894 treatment. CONCLUSION: A TbetaR-I kinase inhibitor decreases the invasiveness and EMT of scirrhous gastric cancer cells. Ki26894 is therefore considered to be a promising therapeutic compound for the metastasis of scirrhous gastric carcinoma.


Subject(s)
Activin Receptors, Type I/antagonists & inhibitors , Adenocarcinoma, Scirrhous/drug therapy , Protein Serine-Threonine Kinases/antagonists & inhibitors , Receptors, Transforming Growth Factor beta/antagonists & inhibitors , Stomach Neoplasms/drug therapy , Activin Receptors, Type I/pharmacology , Adenocarcinoma, Scirrhous/pathology , Animals , Blotting, Western , Cell Movement/drug effects , Female , Mice , Mice, Inbred BALB C , Mice, Nude , Neoplasm Invasiveness , Phosphorylation/drug effects , Protein Serine-Threonine Kinases/metabolism , Receptor, Transforming Growth Factor-beta Type I , Receptor, Transforming Growth Factor-beta Type II , Receptors, Transforming Growth Factor beta/metabolism , Signal Transduction/drug effects , Smad2 Protein/metabolism , Smad3 Protein/metabolism , Stomach Neoplasms/pathology , Transforming Growth Factor beta/pharmacology , Wound Healing/drug effects
3.
Br J Cancer ; 101(7): 1100-6, 2009 Oct 06.
Article in English | MEDLINE | ID: mdl-19738610

ABSTRACT

BACKGROUND: Vascular endothelial growth factor receptor-3 (VEGFR-3) signalling mediates lymphangiogenesis and lymphatic invasion; however, the effect of VEGFR-3 inhibition on the lymph node (LN) metastasis remains unclear. The aim of this study is to clarify the benefit of a VEGFR-3 inhibitor Ki23057 for LN metastasis. METHODS: Ki23057 was administered orally to gastric cancer models created by orthotopic inoculation of diffuse-type gastric cancer cells, OCUM-2MLN. The effects of Ki23057 on lymphatic vessel invasion, lymphatic vessel density, and VEGFR-3 phosphorylation were examined by immunostaining or immunoblotting. RESULTS: Ki23057 inhibited the autophosphorylation of VEGFR-3, with IC50 values of 4.3 nM in the cell-free kinase assay. Murine gastric cancer models created by the orthotopic inoculation of OCUM-2MLN cells showed the diffusely infiltrating growth and frequently developed LN metastasis. The oral administration of Ki23057 significantly (P<0.01) reduced the size of orthotopic tumours and the number of the metastatic LN in gastric cancer models. The degree of lymphatic invasion and lymphangiogenesis was significantly (P<0.05) lower in the gastric tumours treated by Ki23057. Ki23057 inhibited the phosphorylation of VEGFR-3 of lymphatic endothelial cells in gastric tumours. CONCLUSION: The inhibition of lymphangiogenesis targeting VEGFR-3 phosphorylation is a therapeutic strategy for inhibiting LN metastasis of diffuse-type gastric cancer.


Subject(s)
Lymphatic Metastasis/prevention & control , Quinolines/therapeutic use , Stomach Neoplasms/drug therapy , Vascular Endothelial Growth Factor Receptor-3/antagonists & inhibitors , Animals , Cell Line, Tumor , Female , Glycoproteins/analysis , Humans , Lymphangiogenesis/drug effects , Membrane Transport Proteins , Mice , Mice, Inbred BALB C , Phosphorylation , Quinolines/pharmacology , Stomach Neoplasms/blood supply , Stomach Neoplasms/pathology , Vascular Endothelial Growth Factor C/analysis , Vascular Endothelial Growth Factor Receptor-3/metabolism
4.
Science ; 292(5518): 926-9, 2001 May 04.
Article in English | MEDLINE | ID: mdl-11340205

ABSTRACT

Glial cells express a variety of neurotransmitter receptors. Notably, Bergmann glial cells in the cerebellum have Ca2+-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors (AMPARs) assembled without the GluR2 subunit. To elucidate the role of these Ca2+-permeable AMPARs, we converted them into Ca2+-impermeable receptors by adenoviral-mediated delivery of the GluR2 gene. This conversion retracted the glial processes ensheathing synapses on Purkinje cell dendritic spines and retarded the removal of synaptically released glutamate. Furthermore, it caused multiple innervation of Purkinje cells by the climbing fibers. Thus, the glial Ca2+-permeable AMPARs are indispensable for proper structural and functional relations between Bergmann glia and glutamatergic synapses.


Subject(s)
Astrocytes/physiology , Calcium/metabolism , Purkinje Cells/physiology , Receptors, AMPA/metabolism , Synapses/physiology , Synaptic Transmission , Adenoviridae/genetics , Animals , Astrocytes/cytology , Calcium Signaling , Excitatory Postsynaptic Potentials , Genetic Vectors , Green Fluorescent Proteins , In Vitro Techniques , Luminescent Proteins/genetics , Membrane Potentials , Patch-Clamp Techniques , Permeability , Purkinje Cells/cytology , Rats , Receptors, AMPA/genetics , Synapses/metabolism , Transfection , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/pharmacology
5.
Science ; 257(5075): 1401-3, 1992 Sep 04.
Article in English | MEDLINE | ID: mdl-1382313

ABSTRACT

Coronary collateral vessels reduce damage to ischemic myocardium after coronary obstruction. Factors that stimulate collateral formation are expected to have ameliorating effects on myocardial infarction. In a canine experimental myocardial infarct model, intracoronary injection of basic fibroblast growth factor (bFGF) improved cardiac systolic function and reduced infarct size. Treatment with bFGF increased the number of arterioles and capillaries in the infarct. Thus, the angiogenic action of bFGF might lead to a reduction in infarct size. The application of bFGF might bring about a therapeutic modality for the salvage of infarcted myocardium.


Subject(s)
Fibroblast Growth Factor 2/therapeutic use , Myocardial Infarction/drug therapy , Animals , Arterioles/pathology , Capillaries/pathology , Cell Division , Coronary Angiography , Coronary Vessels/pathology , Dogs , Endothelium, Vascular/pathology , Fibroblast Growth Factor 2/administration & dosage , Heart Ventricles/pathology , Muscle, Smooth, Vascular/pathology , Myocardial Infarction/pathology , Neovascularization, Pathologic , Organ Size
6.
Nat Neurosci ; 2(9): 804-11, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10461219

ABSTRACT

A postsynaptic density (PSD) protein, PSD-95, was tagged with green fluorescent protein (GFP-PSD-95) and expressed in cultured hippocampal neurons using recombinant adenoviruses. GFP-PSD-95 was selectively localized to excitatory postsynaptic sites. Time-lapse fluorescence imaging of hippocampal neurons revealed that >20% of GFP-PSD-95 clusters turned over within 24 hours. The appearance rate of clusters was higher than the disappearance rate, and this difference accounted for the gradual increase of the cluster density observed in culture. Dynamics of PSD-95 clusters were also inhibited by blockers of excitatory synaptic transmission. Continual PSD turnover and its regulation by synaptic activity may be important in activity-dependent remodeling of neuronal connections.


Subject(s)
Nerve Tissue Proteins/physiology , Neurons/physiology , Synapses/physiology , 2-Amino-5-phosphonovalerate/pharmacology , 6-Cyano-7-nitroquinoxaline-2,3-dione/pharmacology , Animals , Cells, Cultured , Cloning, Molecular , Dendrites/physiology , Dendrites/ultrastructure , Disks Large Homolog 4 Protein , Embryo, Mammalian , Excitatory Postsynaptic Potentials , Green Fluorescent Proteins , Guanylate Kinases , Hippocampus/cytology , Hippocampus/physiology , Intracellular Signaling Peptides and Proteins , Luminescent Proteins/genetics , Membrane Proteins , Mice , Microscopy, Video , Nerve Tissue Proteins/genetics , Neurons/cytology , Neurons/drug effects , Rats , Recombinant Fusion Proteins/biosynthesis , Synapses/drug effects , Synapses/ultrastructure , Tetrodotoxin/pharmacology , Transfection
7.
Kyobu Geka ; 61(12): 1035-8, 2008 Nov.
Article in Japanese | MEDLINE | ID: mdl-19048903

ABSTRACT

Myxomas are account for approximately half of primary cardiac tumors, and 75% cases originate in left atrium. We report our experience of a right atrial myxoma. A 68-year-old woman was referred to us due to anorexia, general fatigue and facial edema. Echocardiogram, computed tomography (CT), magnetic resonance imaging (MRI), and catheter angiocardiogram revealed a huge tumor in right atrium. The tumor was resected completely with the attached right atrial free wall under cardiopulmonary bypass. Pathological examination showed myxomatous tissue. Postoperative course was uneventful. She discharged the hospital on the 37th day after the operation, and is now doing well without any symptoms.


Subject(s)
Heart Neoplasms/surgery , Myxoma/surgery , Aged , Cardiopulmonary Bypass , Female , Heart Atria , Humans
9.
Oncol Rep ; 15(4): 791-5, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16525660

ABSTRACT

To ascertain the implications of loss of imprinting (LOI) of the insulin-like growth factor II gene (IGF2) for carcinogenesis, the precise frequency of LOI in colorectal carcinoma was examined using a laser capture microdissection method, and compared to the matched normal colorectal mucosa. LOI was examined by PCR-restriction fragment length polymorphism in combination with direct sequencing. The status was assigned as imprinting when PCR-RFLP showed only one band or sequence with a single peak, otherwise cases were classified as LOI. LOI was found in 13 of 24 informative cases of carcinoma (54%), which was higher than the ratios reported previously. LOI was also found in the normal colorectal mucosae in 14 cases (58%). The LOIs in carcinomas and in the normal mucosae were closely correlated: 10 of 13 LOI-positive carcinomas showed LOI in the matched normal mucosae. These results suggest that LOI of IGF2 in colorectal carcinoma and LOI in the background mucosa play important roles in carcinogenesis.


Subject(s)
Colorectal Neoplasms/genetics , Genomic Imprinting/genetics , Insulin-Like Growth Factor II/genetics , Microdissection/methods , Binding Sites/genetics , Colorectal Neoplasms/pathology , DNA, Neoplasm/genetics , DNA, Neoplasm/metabolism , Deoxyribonucleases, Type II Site-Specific/metabolism , Humans , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Lasers , Polymorphism, Genetic , Polymorphism, Restriction Fragment Length
10.
Leukemia ; 19(6): 930-5, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15815726

ABSTRACT

Constitutively active internal tandem duplication (ITD) in the juxtamembrane domain of Fms-like tyrosine kinase 3 (FLT3), a type III receptor tyrosine kinase, is the most common molecular defect associated with acute myeloid leukemia. Its presence confers a poor outcome in patients with acute myeloid leukemia who receive conventional chemotherapy. FLT3-ITD has therefore been considered to be an attractive molecular target for a novel therapeutic modality. We describe here the identification and characterization of Ki23819 as a novel FLT3 inhibitor. Ki23819 suppressed proliferation and induced apoptosis of FLT3-ITD-expressing human leukemia cell lines. The growth-inhibitory effect of Ki23819 on MV4-11 cells was superior to that of SU11248, another FLT3 inhibitor (IC(50)<1 vs 3-10 nM). Ki23819 inhibited the autophosphorylation of FLT3-ITD more efficiently than that of wild-type FLT3. FLT3-ITD-dependent activation of the downstream signaling proteins ERK and STAT5 was also inhibited within similar concentration ranges. Thus, Ki23819 is a potent in vitro inhibitor of FLT3.


Subject(s)
Leukemia, Myeloid/drug therapy , Protein Kinase Inhibitors/pharmacology , Proto-Oncogene Proteins/antagonists & inhibitors , Proto-Oncogene Proteins/genetics , Quinolines/pharmacology , Receptor Protein-Tyrosine Kinases/antagonists & inhibitors , Receptor Protein-Tyrosine Kinases/genetics , Urea/analogs & derivatives , Urea/pharmacology , Acute Disease , Apoptosis/drug effects , Cell Division/drug effects , DNA-Binding Proteins/metabolism , Extracellular Signal-Regulated MAP Kinases/metabolism , HL-60 Cells , Humans , K562 Cells , Leukemia, Myeloid/genetics , Leukemia, Myeloid/metabolism , Milk Proteins/metabolism , Mutation , Phosphorylation/drug effects , Protein Kinase Inhibitors/chemistry , Proto-Oncogene Proteins/metabolism , Quinolines/chemistry , Receptor Protein-Tyrosine Kinases/metabolism , STAT5 Transcription Factor , Trans-Activators/metabolism , Urea/chemistry , fms-Like Tyrosine Kinase 3
11.
Cancer Res ; 45(4): 1845-9, 1985 Apr.
Article in English | MEDLINE | ID: mdl-2983889

ABSTRACT

Streptozotocin and alloxan were administered to Wistar rats in combination with poly(adenosine diphosphate ribose) synthetase inhibitors. Ten to 16 months after the injection of streptozotocin (50 mg/kg body weight i.v.) and 3-aminobenzamide (345 mg/kg i.v.), streptozotocin (50 mg/kg) and nicotinamide (350 mg/kg i.p.), streptozotocin (50 mg/kg) and picolinamide (250 mg/kg i.p.), alloxan (40 mg/kg i.v.) and nicotinamide (350 mg/kg), alloxan (40 mg/kg) and 3-aminobenzamide (345 mg/kg), and alloxan (40 mg/kg) and picolinamide (250 mg/kg), pancreatic islet cell tumors developed in 100, 98, 60, 26, 22, and 20% of surviving rats, respectively. However, after the single injection of streptozotocin and alloxan, islet cell tumors developed in 42 and 11% of surviving rats, respectively. The tumors were rich in B-granules on electron micrographs and contained as large amounts of proinsulin messenger RNA as normal pancreatic islets. The results indicate that poly(adenosine diphosphate ribose) synthetase inhibitors enhance the tumorigenic effect of streptozotocin and alloxan on islet B-cells.


Subject(s)
Adenoma, Islet Cell/chemically induced , Alloxan/toxicity , Insulinoma/chemically induced , NAD+ Nucleosidase/antagonists & inhibitors , Pancreatic Neoplasms/chemically induced , Poly(ADP-ribose) Polymerase Inhibitors , Streptozocin/toxicity , Amides/toxicity , Animals , Male , Niacinamide/toxicity , Picolinic Acids/toxicity , Proinsulin/genetics , RNA, Messenger/analysis , Rats , Rats, Inbred Strains
12.
Cancer Res ; 51(1): 341-8, 1991 Jan 01.
Article in English | MEDLINE | ID: mdl-1824823

ABSTRACT

A new human leukemia cell line with megakaryocytic features, designated UT-7, was established from the bone marrow of a patient with acute megakaryoblastic leukemia. Surface marker analysis revealed that the majority of the cells reacted with monoclonal antibodies against platelet glycoprotein Ib (CD42b), glycoprotein IIb/IIIa (CD41a), MY 7 (CD13), MY 9 (CD33), and glycophorin A antigens. Cytogenetic analysis showed a human male near-tetraploid karyotype with a modal chromosome number of 92-96. Flow cytometry-derived DNA histograms demonstrated that the majority of the cells spontaneously contained 4 N DNA ploidy levels. Ultrastructural study showed that platelet peroxidase activity was weakly positive but myeloperoxidase activity was negative. Ferritin and theta-granule, which have been used as ultrastructural markers for the erythroid lineage, could not be detected. In response to phorbol myristate acetate, platelet factor 4 and beta-thromboglobulin, which were specifically synthesized in the process of megakaryocyte maturation, dramatically increased in UT-7 cells. This was accompanied by an increase in cell size, ploidy level, platelet peroxidase activity, and the surface density of glycoprotein IIb/IIIa antigen. These findings suggest that UT-7 is a new leukemic cell line with megakaryocytic features and with the potential to differentiate into cells with more mature megakaryocytic properties in response to phorbol myristate acetate. This cell line showed strict dependency on interleukin 3 (IL-3), granulocyte-macrophage colony-stimulating factor, or erythropoietin. The maximal effective doses of IL-3, granulocyte-macrophage colony-stimulating factor, and erythropoietin for proliferation in liquid culture were 10 units/ml, 1 ng/ml, and 1 unit/ml, respectively. These concentrations were comparable to the doses that maximally stimulate the clonal growth of normal hemopoietic cells. IL-6 could stimulate the proliferation of UT-7 cells but not maintain the line in long-term culture. UT-7 cells may be a useful model for (a) the analysis of gene regulation of megakaryocytic maturation-associated proteins expressed in the process of megakaryocytic differentiation and (b) the study of signal transduction of hemopoietic factors associated with megakaryocytopoiesis.


Subject(s)
Thrombocythemia, Essential/pathology , Antigens, CD/analysis , Cell Division/drug effects , Cell Survival/drug effects , DNA, Neoplasm/metabolism , Drug Synergism , Erythropoietin/pharmacology , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Hematopoiesis/drug effects , Humans , Interleukin-3/pharmacology , Interleukin-6/pharmacology , Karyotyping , Male , Microscopy, Electron , Middle Aged , Platelet Factor 4/biosynthesis , Tetradecanoylphorbol Acetate/pharmacology , Thrombocythemia, Essential/physiopathology , Tumor Cells, Cultured , beta-Thromboglobulin/biosynthesis
13.
J Neurosci ; 19(18): 7781-92, 1999 Sep 15.
Article in English | MEDLINE | ID: mdl-10479681

ABSTRACT

Subcellular localization of the NMDA receptor NR1 splice forms was studied by expressing individual splice variants and their epitope-tagged derivatives in mouse fibroblasts and in hippocampal neurons. When NR1 splice variants were expressed in fibroblasts, the amount of NR1 molecules expressed on the cell surface varied among forms with different C-terminal cytoplasmic domains. The splice forms with the longest C-terminal cytoplasmic tail (NR1-1a and NR1-1b) showed the lowest amount of cell surface expression, and the splice forms with the shortest C-terminal cytoplasmic tail (NR1-4a and NR1-4b) showed the highest cell surface expression. Cell surface expression of NR1 was enhanced by the coexpression of the NR2 subunit. We measured the glutamate-induced increase of calcium concentration in fibroblasts expressing one of the NR1 splice forms and the NR2B subunit. The increase of calcium concentration after glutamate application had a positive correlation with the amount of NR1 splice forms expressed on the cell surface. When epitope-tagged NR1 splice variants were expressed in primary hippocampal neurons using recombinant adenoviruses, we also observed the differential expression on the cell surface between splice variants. These results suggest that the splicing of the C-terminal domain of the NR1 subunit regulates the cell surface expression of the functional NMDA receptors.


Subject(s)
Alternative Splicing , Gene Expression Regulation , Neurons/metabolism , Receptors, N-Methyl-D-Aspartate/genetics , 3T3 Cells , Animals , COS Cells , Calcium/metabolism , Cell Membrane/metabolism , Gene Expression Regulation/drug effects , Glutamic Acid/pharmacology , Hippocampus/metabolism , Kinetics , Mice , Mutagenesis, Insertional , Protein Structure, Secondary , Receptors, N-Methyl-D-Aspartate/chemistry , Receptors, N-Methyl-D-Aspartate/isolation & purification , Recombinant Proteins/biosynthesis , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification , Transfection
14.
J Neurosci ; 21(16): 6105-14, 2001 Aug 15.
Article in English | MEDLINE | ID: mdl-11487634

ABSTRACT

Hippocampal pyramidal neurons in culture showed a developmental shift in synapse distribution from dendritic shafts to spines. Using dual wavelength time-lapse fluorescence microscopy, we analyzed the morphogenesis of three synaptic components: dendritic spines, postsynaptic densities (PSDs), and presynaptic vesicles. Local assembly of a major PSD protein, PSD-95, was spatially and temporally correlated with spine morphogenesis. Clustering of postsynaptic PSD-95 and that of a predominant synaptic vesicle protein, synaptophysin, were also correlated. In contrast, pre-existing PSD-95 clusters in dendritic shafts were preferentially eliminated without promoting spine formation. The local and stepwise assembly of synaptic components at the contact sites between dendritic protrusions and axons explains the developmental remodeling of excitatory synapses.


Subject(s)
Cell Surface Extensions/metabolism , Nerve Tissue Proteins/metabolism , Pyramidal Cells/metabolism , Synapses/metabolism , Synaptic Vesicles/metabolism , Adenoviridae/genetics , Aging/metabolism , Animals , Axons/metabolism , Axons/ultrastructure , Cell Differentiation , Cell Surface Extensions/ultrastructure , Cells, Cultured , Dendrites/metabolism , Dendrites/ultrastructure , Disks Large Homolog 4 Protein , Genes, Reporter , Guanylate Kinases , Hippocampus , Immunohistochemistry , Intracellular Signaling Peptides and Proteins , Luminescent Proteins/genetics , Membrane Proteins , Mice , Microscopy, Fluorescence , Nerve Tissue Proteins/genetics , Protein Transport/physiology , Pseudopodia/metabolism , Pseudopodia/ultrastructure , Pyramidal Cells/ultrastructure , Rats , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Synapses/ultrastructure , Synaptic Vesicles/ultrastructure , Synaptophysin/metabolism , Transfection
15.
J Neurosci ; 20(8): 2875-86, 2000 Apr 15.
Article in English | MEDLINE | ID: mdl-10751440

ABSTRACT

Motoneurons require neurotrophic factors for their survival and axonal projection during development, as well as nerve regeneration. By using the axotomy-induced neuronal death paradigm and adenovirus-mediated gene transfer, we attempted to gain insight into the functional significances of major growth factor receptor downstream cascades, Ras-extracellular signal-regulated kinase (Ras-ERK) pathway and phosphatidylinositol-3 kinase-Akt (PI3K-Akt) pathway. After neonatal hypoglossal nerve transection, the constitutively active Akt-overexpressing neurons could survive as well as those overexpressing Bcl-2, whereas the constitutively active ERK kinase (MEK)-overexpressing ones failed to survive. A dominant negative Akt experiment demonstrated that inhibition of Akt pathway hastened axotomy-induced neuronal death in the neonate. In addition, the dominant active Akt-overexpressing adult hypoglossal neurons showed accelerated axonal regeneration after axotomy. These results suggest that Akt plays dual roles in motoneuronal survival and nerve regeneration in vivo and that PI3K-Akt pathway is probably more vital in neuronal survival after injury than Ras-ERK pathway.


Subject(s)
Cell Death/physiology , Motor Neurons/physiology , Nerve Regeneration/physiology , Protein Serine-Threonine Kinases , Proto-Oncogene Proteins/physiology , Animals , Animals, Newborn , Axotomy , Enzyme Activation , Gene Transfer Techniques , Genetic Vectors/physiology , Hypoglossal Nerve/physiology , Hypoglossal Nerve Injuries , Neurites/physiology , PC12 Cells , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins c-akt , Rats
16.
Biochim Biophys Acta ; 1550(1): 70-80, 2001 Nov 26.
Article in English | MEDLINE | ID: mdl-11738089

ABSTRACT

A novel antimicrobial peptide, anoplin, was purified from the venom of the solitary wasp Anoplius samariensis. The sequence was mostly analyzed by mass spectrometry, which was corroborated by solid-phase synthesis. Anoplin, composed of 10 amino acid residues, Gly-Leu-Leu-Lys-Arg-Ile-Lys-Thr-Leu-Leu-NH2, has a high homology to crabrolin and mastoparan-X, the mast cell degranulating peptides from social wasp venoms, and, therefore, can be predicted to adopt an amphipathic alpha-helix secondary structure. In fact, the circular dichroism (CD) spectra of anoplin in the presence of trifluoroethanol or sodium dodecyl sulfate showed a high content, up to 55%, of the alpha-helical conformation. A modeling study of anoplin based on its homology to mastoparan-X supported the CD results. Biological evaluation using the synthetic peptide revealed that this peptide exhibited potent activity in stimulating degranulation from rat peritoneal mast cells and broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria. Therefore, this is the first antimicrobial component to be found in the solitary wasp venom and it may play a key role in preventing potential infection by microorganisms during prey consumption by their larvae. Moreover, this peptide is the smallest among the linear alpha-helical antimicrobial peptides hitherto found in nature, which is advantageous for chemical manipulation and medical application.


Subject(s)
Anti-Bacterial Agents/isolation & purification , Oligopeptides/chemistry , Oligopeptides/isolation & purification , Wasp Venoms/chemistry , Wasp Venoms/isolation & purification , Amino Acid Sequence , Animals , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Antimicrobial Cationic Peptides , Cell Degranulation , Chromatography, High Pressure Liquid , Circular Dichroism , Female , Mast Cells/drug effects , Mast Cells/physiology , Microbial Sensitivity Tests , Models, Molecular , Oligopeptides/pharmacology , Rats , Sequence Alignment , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Wasp Venoms/pharmacology , Wasps
17.
J Gen Physiol ; 110(6): 665-77, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9382895

ABSTRACT

The number, sign, and distribution of charged residues in the pore-forming H5 domain for inward-rectifying K channels (IRK1) are different from the otherwise homologous H5 domains of other voltage-gated K channels. We have mutated Arg148, which is perfectly conserved in all inward rectifiers, to His in the H5 of IRK1 (Kir2. 1). Channel activity was lost by the mutation, but coexpression of the mutant (R148H) along with the wild-type (WT) mRNA revealed populations of channels with reduced single-channel conductances. Long-lasting and flickery sublevels were detected exclusively for the coexpressed channels. These findings indicated that the mutant subunit formed hetero-oligomers with the WT subunit. The permeability ratio was altered by the mutation, while the selectivity sequence (K+ > Rb+ > NH4+ >> Na+) was preserved. The coexpression made the IRK1 channel more sensitive to extracellular block by Mg2+ and Ca2+, and turned this blockade from a voltage-independent to a -dependent process. The sensitivity of the mutant channels to Mg2+ was enhanced at higher pH and by an increased ratio of mutant:WT mRNA, suggesting that the charge on the Arg site controlled the sensitivity. The blocking rate of open channel blockers, such as Cs+ and Ba2+, was facilitated by coexpression without significant change in the steady state block. Evaluation of the electrical distance to the binding site for Mg2+ or Ca2+ and that to the barrier peak for block by Cs+ or Ba2+ suggest that Arg148 is located between the external blocking site for Mg2+ or Ca2+ and the deeper blocking site for Cs+ or Ba2+ in the IRK1 channel. It is concluded that Arg148 serves as a barrier to cationic blockers, keeping Mg2+ and Ca2+ out from the electric field of the membrane.


Subject(s)
Arginine/physiology , Cations/pharmacology , Ion Channel Gating/physiology , Potassium Channels, Inwardly Rectifying , Potassium Channels/chemistry , Potassium Channels/genetics , Animals , Barium/pharmacology , Calcium/pharmacology , Cells, Cultured , Cesium/pharmacology , Electrophysiology , Gene Expression/physiology , Hydrogen-Ion Concentration , Ion Channel Gating/drug effects , Magnesium/pharmacology , Molecular Sequence Data , Mutagenesis, Site-Directed/physiology , Oocytes/chemistry , Oocytes/physiology , Sensitivity and Specificity , Sequence Homology, Amino Acid , Xenopus
18.
J Cereb Blood Flow Metab ; 12(3): 408-17, 1992 May.
Article in English | MEDLINE | ID: mdl-1569136

ABSTRACT

Slice preparations were made from the hippocampus of gerbils after 5 min of ischemia by carotid artery occlusion and the membrane properties of pyramidal neurons were examined. A majority of CA1 neurons lost the capacity for long-term potentiation following tetanic stimulation of the input fibers. CA3 pyramidal neurons, in contrast, preserved responses similar to those in the normal gerbil. Following ischemia, CA1 pyramidal neurons showed increased spontaneous firing that was highly voltage dependent and was blocked by intracellular injection of the Ca2+ chelator, EGTA. Thirty-five percent of CA1 neurons showed an abnormal slow oscillation of the membrane potential after 24 h following ischemia. Intracellular injection of GTP gamma S or IP3 produced facilitation of the oscillations followed by irreversible depolarization. Our results indicate that ischemia-damaged CA1 neurons suffer from abnormal Ca2+ homeostasis, involving IP3-induced liberation of Ca2+ from internal stores.


Subject(s)
Calcium/analysis , Hippocampus/physiopathology , Ischemic Attack, Transient/physiopathology , Pyramidal Tracts/physiopathology , Animals , Cell Death , Disease Models, Animal , Egtazic Acid/pharmacology , Gerbillinae , Guanosine 5'-O-(3-Thiotriphosphate)/pharmacology , Inositol 1,4,5-Trisphosphate/pharmacology , Male , Membrane Potentials/drug effects , Reperfusion
19.
Gene ; 140(1): 73-7, 1994 Mar 11.
Article in English | MEDLINE | ID: mdl-8125343

ABSTRACT

We cloned and sequenced two Escherichia coli genes which are members of a family of an environmentally responsive two-component system. The nucleotide (nt) and deduced amino-acid sequences of these two genes were found to be homologous to those of the Bordetella pertussis bvgA and bvgS genes. They were mapped at 51 min (clones 6B9 to 7G9 of the Kohara miniset library of the E. coli chromosome). Both proteins, deduced from their nt sequences, were identified in the coupled in vitro transcription-translation system; their molecular masses were consistent with BvgA and BvgS (23 and 135 kDa, respectively). Furthermore, when these genes were expressed on a multicopy plasmid in an envZ deletion strain, ompC expression was induced. This expression was found to be regulated by low temperature, MgSO4 and nicotinic acid, factors known to control the virulence of B. pertussis via BvgA and BvgS. These results indicate that the newly cloned genes were structurally and functionally similar to bvgA and bvgS, and we designated these genes evgA and evgS.


Subject(s)
Bacterial Proteins/genetics , Escherichia coli Proteins , Escherichia coli/genetics , Signal Transduction/genetics , Transcription Factors/genetics , Amino Acid Sequence , Bacterial Outer Membrane Proteins/genetics , Bacterial Proteins/metabolism , Base Sequence , Cloning, Molecular , DNA, Recombinant , Escherichia coli/metabolism , Gene Expression Regulation , Genes, Bacterial , Genes, Suppressor , Molecular Sequence Data , Mutation , Sequence Analysis, DNA , Transcription Factors/metabolism
20.
Am J Cardiol ; 71(15): 1316-20, 1993 Jun 01.
Article in English | MEDLINE | ID: mdl-8498373

ABSTRACT

To assess autonomic nervous activity in patients with cardiomyopathies, analysis of heart rate variability was performed using 24-hour ambulatory electrocardiograms in 14 patients with idiopathic dilated cardiomyopathy (IDC), 15 with hypertrophic cardiomyopathy (HC) and 18 healthy subjects. Heart rate variability during the night and daytime was calculated using fast-Fourier transform, and power spectra were quantified in 2 frequency bandwidths: 0.00 to 0.15 Hz (low-frequency power [LF]) and 0.15 to 0.50 Hz (high-frequency power [HF]). Log(HF) was used as an index of parasympathetic nervous activity, and log(LF/HF), of sympathetic nervous activity. Log(HF) was significantly lower and log(LF/HF) was significantly higher in IDC. These changes were related to ejection fraction. In HC, lower log(HF) and higher log(LF/HF) were recognized only during the night, and these changes were independent of the degree of myocardial hypertrophy. Our results indicated attenuation of parasympathetic activity and enhanced sympathetic activity in HC during the night, and also in IDC. Assessment of autonomic imbalance by analysis of heart rate variability may be useful for understanding the pathophysiology of cardiomyopathies.


Subject(s)
Autonomic Nervous System/physiopathology , Cardiomyopathy, Dilated/physiopathology , Cardiomyopathy, Hypertrophic/physiopathology , Heart Rate/physiology , Electrocardiography, Ambulatory/methods , Female , Fourier Analysis , Humans , Male , Middle Aged , Signal Processing, Computer-Assisted
SELECTION OF CITATIONS
SEARCH DETAIL